LIVIVO - The Search Portal for Life Sciences

zur deutschen Oberfläche wechseln
Advanced search

Search results

Result 1 - 1 of total 1

Search options

Article ; Online: Association of serum HDL-cholesterol and apolipoprotein A1 levels with risk of severe SARS-CoV-2 infection.

Hilser, James R / Han, Yi / Biswas, Subarna / Gukasyan, Janet / Cai, Zhiheng / Zhu, Ruowei / Tang, W H Wilson / Deb, Arjun / Lusis, Aldons J / Hartiala, Jaana A / Allayee, Hooman

Journal of lipid research

2021  Volume 62, Page(s) 100061

Abstract: ... of SARS-CoV-2 infection. These results implicate serum HDL-cholesterol and apolipoprotein A1 levels ... controls, a 10 mg/dl increase in serum HDL-cholesterol or apolipoprotein A1 levels was associated with ∼10 ... provide evidence that genetically elevated HDL-cholesterol levels are associated with SAR-CoV-2 infection. ...

Abstract Individuals with features of metabolic syndrome are particularly susceptible to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), a novel coronavirus associated with the severe respiratory disease, coronavirus disease 2019 (COVID-19). Despite considerable attention dedicated to COVID-19, the link between metabolic syndrome and SARS-CoV-2 infection remains unclear. Using data from the UK Biobank, we investigated the relationship between severity of COVID-19 and metabolic syndrome-related serum biomarkers measured prior to SARS-CoV-2 infection. Logistic regression analyses were used to test biomarker levels and biomarker-associated genetic variants with SARS-CoV-2-related outcomes. Among SARS-CoV-2-positive cases and negative controls, a 10 mg/dl increase in serum HDL-cholesterol or apolipoprotein A1 levels was associated with ∼10% reduced risk of SARS-CoV-2 infection, after adjustment for age, sex, obesity, hypertension, type 2 diabetes, and coronary artery disease. Evaluation of known genetic variants for HDL-cholesterol revealed that individuals homozygous for apolipoprotein E4 alleles had ∼2- to 3-fold higher risk of SARS-CoV-2 infection or mortality from COVID-19 compared with apolipoprotein E3 homozygotes, even after adjustment for HDL-cholesterol levels. However, cumulative effects of all evaluated HDL-cholesterol-raising alleles and Mendelian randomization analyses did not reveal association of genetically higher HDL-cholesterol levels with decreased risk of SARS-CoV-2 infection. These results implicate serum HDL-cholesterol and apolipoprotein A1 levels measured prior to SAR-CoV-2 exposure as clinical risk factors for severe COVID-19 infection but do not provide evidence that genetically elevated HDL-cholesterol levels are associated with SAR-CoV-2 infection.
MeSH term(s) Adult ; Aged ; Apolipoprotein A-I/blood ; Apolipoprotein A-I/genetics ; Biomarkers/blood ; COVID-19/blood ; COVID-19/genetics ; COVID-19/mortality ; Cholesterol, HDL/blood ; Cholesterol, HDL/genetics ; Female ; Homozygote ; Humans ; Male ; Metabolic Syndrome/blood ; Metabolic Syndrome/genetics ; Metabolic Syndrome/mortality ; Middle Aged ; Patient Acuity ; SARS-CoV-2/metabolism ; United Kingdom/epidemiology
Chemical Substances Apolipoprotein A-I ; Biomarkers ; Cholesterol, HDL
Language English
Publishing date 2021-03-02
Publishing country United States
Document type Journal Article ; Multicenter Study ; Research Support, N.I.H., Extramural
ZDB-ID 80154-9
ISSN 1539-7262 ; 0022-2275
ISSN (online) 1539-7262
ISSN 0022-2275
DOI 10.1016/j.jlr.2021.100061
Shelf mark
Zs.A 175: Show issues Location:
Je nach Verfügbarkeit (siehe Angabe bei Bestand)
bis Jg. 1994: Bestellungen von Artikeln über das Online-Bestellformular
Jg. 1995 - 2021: Lesesall (1.OG)
ab Jg. 2022: Lesesaal (EG)
Database MEDical Literature Analysis and Retrieval System OnLINE

More links

Kategorien

To top